Susquehanna International Group’s Akero Therapeutics AKRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $2.41M | Sell |
|
|||||
|
2025
Q2 | $11.1M | Buy |
|
|||||
|
2025
Q1 | $7.3M | Buy |
|
|||||
|
2024
Q4 | $981K | Buy |
|
|||||
|
2024
Q3 | $617K | Sell |
|
|||||
|
2024
Q2 | $831K | Sell |
|
|||||
|
2024
Q1 | $2.63M | Buy |
|
|||||
|
2023
Q4 | $507K | Sell |
|
|||||
|
2023
Q3 | $17.7M | Buy |
|
|||||
|
2023
Q2 | $4.41M | Sell |
|
|||||
|
2023
Q1 | $3.78M | Buy |
|
|||||
|
2022
Q4 | $1.95M | Sell |
|
|||||
|
2022
Q3 | $2.48M | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $391K | Sell |
|
|||||
|
2021
Q4 | $1.19M | Buy |
|
|||||
|
2021
Q3 | $1.13M | Sell |
|
|||||
|
2021
Q2 | $1.87M | Sell |
|
|||||
|
2021
Q1 | $6.47M | Buy |
|
|||||
|
2020
Q4 | $368K | Sell |
|
|||||
|
2020
Q3 | $711K | Sell |
|
|||||
|
2020
Q2 | $702K | Sell |
|
|||||
|
2020
Q1 | $634K | Buy |
|